• Sign In to gain access to subscriptions and/or My Tools.
Impact Factor:4.822 | Ranking:Clinical Neurology 22 out of 192
Source:2014 Journal Citation Reports® (Thomson Reuters, 2015)

Multiple Sclerosis Journal

Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. 

The journal for your research in the following areas:

  • Biologic basis: pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics
  • Epidemology and genetics: genetics epigenetics, epidemiology
  • Clinical and Neuroimaging: clinical neurology, biomarkers, neuroimaging and clinical outcome measures
  • Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management

Outstanding information presented in a topical based format.

This journal is a member of the Committee on Publication Ethics (COPE)

Average time from submission to first decision: 32 days

Now free to access: “Controversies in MS”: a new series of debates published regularly in the journal since October 2011, see the introduction here. Read both sides of the debate on a wide range of key topics. Look for the “Controversies” section in issues published from October 2011.